HealthcareServices

Assisted Reproductive Technology Market Research: Growth Projections and Trends 2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the assisted reproductive technology market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Assisted Reproductive Technology Market be in 2030 compared with 2026?

The assisted reproductive technology market has shown significant expansion in recent years. Its valuation is projected to rise from $37.06 billion in 2025 to $40.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historical growth can be ascribed to several factors, including an increase in infertility prevalence, the trend of women having children at older ages, the expansion of fertility clinics, the broader accessibility of assisted reproductive procedures, and a growing societal acceptance of ART treatments.

The assisted reproductive technology market size is set to experience significant expansion in the next few years. It is expected to grow to $56.96 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This projected growth during the forecast period can be attributed to factors such as the increasing adoption of precision fertility diagnostics, rising investments in fertility treatment infrastructure, broader expansion of genetic testing applications, a growing demand for minimally invasive procedures, and increased healthcare spending on reproductive health. Major trends anticipated in this period include the increasing adoption of advanced embryo screening techniques, a rising use of frozen embryo and egg banking, a growing demand for personalized fertility treatments, the expansion of genetic testing in art procedures, and an enhanced focus on treatment success rates.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

What Drivers Are Guiding Growth Patterns In The Assisted Reproductive Technology Market?

The increasing incidence of infertility is projected to fuel expansion in the assisted reproductive technology market in the foreseeable future. Infertility is characterized by the inability to achieve pregnancy after one year of regular, unprotected sexual activity. This condition impacts both genders and is commonly identified when conception does not occur. Assisted reproductive technology (ART) serves as a treatment for infertility, encompassing fertility therapies that involve both a woman’s egg and a man’s sperm. For example, in April 2023, the World Health Organization (WHO), an international public health organization based in Switzerland, reported that millions of reproductive-aged individuals globally contend with infertility, impacting their families and communities. Worldwide, approximately 1 in 6 adults, equating to about 17.5% of the global adult population, are estimated to experience infertility. Consequently, the growing prevalence of infertility cases is a key factor propelling the expansion of the assisted reproductive technology market.

How Is The Assisted Reproductive Technology Market Divided Into Segments?

The assisted reproductive technology market covered in this report is segmented –

1) By Diagnosis: Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing

2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking

3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Subsegments:

1) By Hysterosalpingography (HSG): X-ray HSG, Sonohysterography (SHG)

2) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, Antral Follicle Count (AFC) via Ultrasound

3) By Genetic Testing: Preimplantation Genetic Testing (PGT), Carrier Screening Tests, Genetic Compatibility Testing

Which Trends Are Influencing The Performance And Direction Of The Assisted Reproductive Technology Market?

Leading companies in the assisted reproductive technology market are concentrating on developing advanced solutions, such as next-generation sequencing (NGS)-based testing kits, to improve chromosomal analysis, enhance embryo selection, and increase the success rates of fertility treatments. NGS-based preimplantation genetic testing refers to research-use technologies that enable comprehensive assessment of chromosomal abnormalities in embryos, supporting informed decision-making during IVF and ICSI procedures. For instance, in July 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched two next-generation sequencing-based products, the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, to support preimplantation genetic testing for aneuploidy (PGT-A). Designed for reproductive health laboratories, these assays are the first research-use products of their kind and are compatible with the Ion Torrent Genexus Integrated Sequencer, enabling a streamlined workflow from sample processing to aneuploidy analysis. PGT-A testing helps identify chromosomal abnormalities in embryo samples, and these new solutions aim to advance scientific understanding, improve pregnancy success rates, and promote healthier outcomes for future generations. The Genexus platform further simplifies the research process through integrated templating, sequencing, and data analysis, while the Ion AmpliSeq Polyploidy Panel kit offers enhanced quality control features to detect contamination, avoid sample mix-ups, and identify triploidy in embryos, reinforcing technological progress within the assisted reproductive technology market.

Which Leading Companies Dominate The Assisted Reproductive Technology Market Share?

Major companies operating in the assisted reproductive technology market are Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

How Does The Assisted Reproductive Technology Market Perform Across Major Global Regions?

Europe was the largest region in the assisted reproductive technology market in 2025. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Assisted Reproductive Technology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5489&type=smp

Browse Through More Reports Similar to the Global Assisted Reproductive Technology Market 2026, By The Business Research Company

Infertility Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

Fertility Treatments Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Fertility Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795